Resilience Through Interventions for Successful Early Outcomes
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Oct 30, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Resilience Through Interventions for Successful Early Outcomes," is looking at a parenting program called Attachment and Biobehavioral Catch-up (ABC). The goal is to see how this program can help reduce stress in young children aged 24 to 54 months who have faced difficult situations in their lives. The study will involve about 150 caregiver-child pairs, focusing on those who speak English or Spanish and have experienced social challenges.
If you and your child qualify for the study, you will be randomly chosen to either start the ABC parenting program right away or wait for about four months before beginning. The program consists of 10 sessions. Throughout the study, caregivers will fill out online surveys, participate in fun play activities with their children, and provide simple biological samples like saliva and hair. This research is important as it aims to improve the relationship between caregivers and children while also addressing children's mental health needs. To be eligible, caregivers must be at least 18 years old, be the primary guardian of a child in the specified age range, and live in a supportive home environment. Certain medical conditions in children may exclude them from participating.
Gender
ALL
Eligibility criteria
- Parent/Caregiver Inclusion Criteria :
- • Aged 18 or older
- • Speaks English or Spanish
- • Is the parent or legal guardian with legal custody of a child aged between 24 months and 42 months
- • Is a primary caregiver/parent
- • Has a home-like environment in which to participate in the intervention
- Child Inclusion Criteria:
- • Aged between 24 months and 42 months at enrollment
- • Lives with the parent/caregiver at least 50% of the time
- • Has experienced social risk factors, including low income, community or family violence, previous trauma/adversity exposure, prolonged separation from caregiver, significant difficulties in relationship with caregiver Child Exclusion Criteria
- • Has a diagnosed genetic or congenital disorders, including but not limited to Down syndrome, cerebral palsy, seizure disorders, endocrine disorders (or is using steroid medications, including human growth hormone), or was born with birth defects
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Chapel Hill, South Carolina, United States
Patients applied
Trial Officials
Danielle Roubinov, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported